The problem with TAM
Total Addressable Market (TAM) is a ubiquitous metric in biotech investment pitches, used to quantify the theoretical revenue potential of
The Problem with CAGR
Biotech investing is not for the faint-hearted. This field, ruled by unpredictability, is a theatre of sharp turns: clinical trials
Fat-Tailed Distributions and Black Swan Events: Why They Matter
The concepts of fat-tailed distributions and black swan events, as popularized by Nassim Nicholas Taleb in seminal work "The
Exploring Outliers: How Rare Events Shape My Thinking
Hi, I’m Sebastian, and this blog is both an indulgence and an exploration. It’s not for any one